Madrigal Pharmaceuticals (MDGL) PT Lowered to $166 at Citi
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $507.56 +0.04%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Joel Beatty lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $166.00 (from $173.00) while maintaining a Buy rating.
You May Also Be Interested In
- Madrigal Pharmaceuticals adds J&J executive to its board
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
